Biomedicines · 2024 · 15 citations · 17 references
MedicineEndocrinologyClinical EpidemiologyEpidemiologic MethodsEpidemiologyMetabolic DiseaseMetabolic DisordersMetabolic HealthMetabolic SyndromeCohort Study InvestigationConsensusHyperferritinemic SyndromesMetabolic ComorbidityMetabolic Disease Etiology
BACKGROUND: Hyperferritinemia (HF) is a common finding and can be considered as metabolic HF (MHF) in combination with metabolic diseases. The definition of MHF was heterogenous until a consensus statement was published recently. Our aim was to apply the definition of MHF to provide data on the prevalence and characteristics of MHF in a Central-European cohort. METHODS: This study was a retrospective analysis of the Paracelsus 10,000 study, a population-based cohort study from the region of Salzburg, Austria. We included 8408 participants, aged 40-77. Participants with HF were divided into three categories according to their level of HF and evaluated for metabolic co-morbidities defined by the proposed criteria for MHF. RESULTS: HF was present in 13% (n = 1111) with a clear male preponderance (n = 771, 69% of HF). Within the HF group, 81% (n = 901) of subjects fulfilled the metabolic criteria and were defined as MHF, of which 75% (n = 674) were characterized by a major criterion. In the remaining HF cohort, 52% (n = 227 of 437) of subjects were classified as MHF after application of the minor criteria. CONCLUSION: HF is a common finding in the general middle-aged population and the majority of cases are classified as MHF. The new classification provides useful criteria for defining MHF.
17
Insulin resistance–associated hepatic iron overload
Michel-Henry Mendler, Bruno Turlin, Romain Moirand et al. · Gastroenterology · 1999 · 505 citations · Full text